 | Up a level |
Scully, Marie; Antun, Ana; Cataland, Spero R; Coppo, Paul; Dossier, Claire; Biebuyck, Nathalie; Hassenpflug, Wolf-Achim; Kentouche, Karim; Knöbl, Paul; Kremer Hovinga, Johanna A; López-Fernández, M Fernanda; Matsumoto, Masanori; Ortel, Thomas L; Windyga, Jerzy; Bhattacharya, Indranil; Cronin, Michael; Li, Hong; Mellgård, Björn; Patel, Munjal; Patwari, Parth; ... (2024). Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura. The New England journal of medicine, 390(17), pp. 1584-1596. Massachusetts Medical Society 10.1056/NEJMoa2314793
De Waele, Laure; Sakai, Kazuya; Mancini, Ilaria; Sinkovits, György; Falter, Tanja; Inoue, Takashi; Agosti, Pasquale; Rossmann, Heidi; Von Auer, Charis; Tersteeg, Claudia; De Meyer, Simon F; Joly, Bérangère S; Veyradier, Agnès; Coppo, Paul; Fijnheer, Rob; Peyvandi, Flora; Prohászka, Zoltán; Lämmle, Bernhard; Vanhoorelbeke, Karen (2024). Open ADAMTS13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis, 22(2), pp. 493-502. Wiley-Blackwell 10.1016/j.jtha.2023.10.014
Scully, Marie; de la Rubia, Javier; Pavenski, Katerina; Metjian, Ara; Knöbl, Paul; Peyvandi, Flora; Cataland, Spero; Coppo, Paul; Kremer Hovinga, Johanna A; Minkue Mi Edou, Jessica; De Passos Sousa, Rui; Callewaert, Filip; Gunawardena, Sriya; Lin, Julie (2022). Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study. Journal of thrombosis and haemostasis, 20(12), pp. 2810-2822. Wiley-Blackwell 10.1111/jth.15892
Balduini, Carlo; Freson, Kathleen; Greinacher, Andreas; Gresele, Paolo; Kühne, Thomas; Scully, Marie; Bakchoul, Tamam; Coppo, Paul; Dovc Drnovsek, Tadeja; Godeau, Bertrand; Gruel, Yves; Rao, A Koneti; Kremer Hovinga, Johanna A.; Makris, Michael; Matzdorff, Axel; Mumford, Andrew; Pecci, Alessandro; Raslova, Hana; Rivera, José; Roberts, Irene; ... (2021). The EHA Research Roadmap: Platelet Disorders. HemaSphere, 5(7), e601. Wolters Kluwer Health 10.1097/HS9.0000000000000601
Peyvandi, Flora; Cataland, Spero; Scully, Marie; Coppo, Paul; Knoebl, Paul; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Minkue Mi Edou, Jessica; De Winter, Hilde; Callewaert, Filip (2021). Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis. Blood advances, 5(8), pp. 2137-2141. American Society of Hematology 10.1182/bloodadvances.2020001834
Cuker, Adam; Cataland, Spero R; Coppo, Paul; de la Rubia, Javier; Friedman, Kenneth D; George, James N; Knoebl, Paul N; Kremer Hovinga, Johanna A.; Lämmle, Bernhard; Matsumoto, Masanori; Pavenski, Katerina; Peyvandi, Flora; Sakai, Kazuya; Sarode, Ravi; Thomas, Mari R; Tomiyama, Yoshiaki; Veyradier, Agnès; Westwood, John-Paul; Scully, Marie (2021). Redefining outcomes in immune TTP: an international working group consensus report. Blood, 137(14), pp. 1855-1861. American Society of Hematology 10.1182/blood.2020009150
Knoebl, Paul; Cataland, Spero; Peyvandi, Flora; Coppo, Paul; Scully, Marie; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Minkue Mi Edou, Jessica; De Winter, Hilde; Callewaert, Filip (2020). Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. Journal of thrombosis and haemostasis, 18(2), pp. 479-484. Wiley-Blackwell 10.1111/jth.14679
Scully, Marie; Cataland, Spero R; Peyvandi, Flora; Coppo, Paul; Knöbl, Paul; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Callewaert, Filip; Biswas, Debjit; De Winter, Hilde; Zeldin, Robert K (2019). Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. The New England journal of medicine, 380(4), pp. 335-346. Massachusetts Medical Society 10.1056/NEJMoa1806311
Kremer Hovinga, Johanna Anna; Coppo, Paul; Lämmle, Bernhard; Moake, Joel L; Miyata, Toshiyuki; Vanhoorelbeke, Karen (2017). Thrombotic thrombocytopenic purpura. Nature reviews. Disease Primers, 3(17020), p. 17020. Nature Publishing Group 10.1038/nrdp.2017.20
